Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276 Hold
15
﹤0.01% 492
2026
Q1
$303 Hold
15
﹤0.01% 484
2025
Q4
$288 Buy
+15
New +$316 ﹤0.01% 476

Other funds holding ADNT

McMillan Office's ADNT Position: Q2 2026 in Review

McMillan Office held its Adient (ADNT) position steady in Q2 2026 at 15 shares worth $276. The position accounts for ﹤0.01% of the portfolio, ranked #492.

McMillan Office first reported a position in ADNT in Q4 2025 and has held it in 3 quarters since. The position peaked at $303 in Q1 2026. 312 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • McMillan Office held 15 shares of Adient worth $276 as of Q2 2026.
  • McMillan Office left its Adient share count unchanged in Q2 2026.
  • Adient made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #492 holding.
  • McMillan Office first reported a position in Adient in Q4 2025 and has held it in 3 quarters since.
  • McMillan Office's Adient position peaked at $303 in Q1 2026.
  • 312 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.